Diagnostic Biosystems

Search Product:  

Home Company  |  Products  |  Services  |  R&D  |  Partnership  |  Contact US  | 

 
  

Services

Anti-cancer new drug R&D platform
Comprehensive Solutions for Apoptosis Research
 
Comprehensive Solutions for Apoptosis Research
   
     ★In vitro and in vivo anti-cancer drug screening and evaluation
      KeyGen has built the cancer cell bank with aver 150 different cell lines for cancer research and anti-cancer drug development. This cancer cell bank includes human head and neck cancer, respiration system cancer, digestive system cancer, women cancer and urological system cancer, nerve system cancer, blood cancer and sarcoma, melanoma, etc. Besides human cancer cell lines, KeyGen cell bank also includes the cancer cell lines and normal cell lines from other species such as mouse, rats, hamster, monkey, dog, etc. KeyGen has also setup the experimental animal center with 600 mm2 at specific pathogen free conditions (SPF) level suitable for nude mice and SCID mice raising, which guarantees the in vivo activity evaluation, preliminary toxicity evaluation and drug discovery.
     ★Cell apoptosis detection techniques
      To induce cancer cell apoptosis is an important strategy for anti-cancer new drug development. KeyGen has setup multiple methods for cell apoptosis detection by making use of KeyGen’s cancer cell bank. About twenty cell apoptosis detection kits have been successfully developed. The high-throughput anti-cancer new drug screening technique has been developed based on cancer cell apoptosis, which will enable the screening and discovery of cancer cell apoptosis inducer.
     On this platform KeyGen provides the services based on the resources as following:
                   Human Tumor Cell Lines For In vitro and In vivo Anti-cancer Drug Screening
     Scientific service items
     (1)、In vitro and in vivo anti-cancer drug screening and evaluation
      KeyGen has multiple research models at cellular or molecular level, experimental animal base with SPF facilities, which provide the environment for anti-cancer drug screening and evaluation for clients from all over the world. 
     
Name of the models
a、In vivo model using nude mice bearing cancer for anti-cancer drug evaluation
b. In vivo angiogenesis model for anti-cancer drug evaluation
c、In vitro cancer cell growth inhibition model/td>
d、Cell apoptosis model
……
 
     (2)、Customer service of preparation of nude mice bearing cancer
      KeyGen has setup the SPF facilities for anti-cancer drug evaluation using nude mice. We can provide services of the preparation of nude mice bearing different cancer cells originated from different human tissue, which will enable the further in vivo anti-cancer evaluation.
     (3)、Acute toxicity evaluation
      KeyGen provides the studies of acute toxicity evaluation with the drug given by different routes such as oral, i.v., i.p., etc. The reports of half lethal dosage (LD50) and maximum tolerance dosage.
     The prices of services are as follows: 
   
ServicePrice
In vitro anti-cancer drug screening and evaluation one drug (five different doses) using one cancer cell line costs 600$.
In vivo anti-cancer drug screening and evaluation one drug (three different doses) using one cancer cell nude mice xenograft model costs 12,000$.
Acute toxicity evaluation one drug costs $3,000 USD.
 
     There is an example of a report on anticancer effect of three topotecan derivatives in nude mice xenograft model we had done for our client.